Carson Wealth (CWM LLC)’s Turning Point Therapeutics, Inc. Common Stock TPTX Stock Holding History

Carson Wealth (CWM LLC)’s Portfolio TPTX Stock Details TPTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-4	Closed	–	–	4331
2022 Q2	$0	Sell	4 -8	-67%	-$356	﹤0.01%	4224
2022 Q1	$0	Sell	12 -5	-29%	-$168	﹤0.01%	4015
2021 Q4	$1K	Buy	+17	New	+$760	﹤0.01%	3456
2021 Q2	$0	Hold	4	–	–	﹤0.01%	3040
2021 Q1	$0	Hold	4	–	–	﹤0.01%	3037
2020 Q4	$0	Hold	4	–	–	﹤0.01%	3034
2020 Q3	$0	Hold	4	–	–	﹤0.01%	3031
2020 Q2	$0	Hold	4	–	–	﹤0.01%	3029
2020 Q1	$0	Hold	4	–	–	﹤0.01%	3026
2019 Q4	$0	Hold	4	–	–	﹤0.01%	3024
2019 Q3	$0	Hold	4	–	–	﹤0.01%	3024
2019 Q2	$0	Buy	+4	New	+$143	﹤0.01%	3023

Carson Wealth (CWM LLC)'s TPTX Position: Q3 2022 in Review

Carson Wealth (CWM LLC) sold out of Turning Point Therapeutics, Inc. Common Stock (TPTX) in Q3 2022, closing a stake of 4 shares.

Carson Wealth (CWM LLC) first reported a position in TPTX in Q2 2019 and held it in 12 quarters. The position peaked at $1K in Q4 2021. 0 funds tracked by Wall St. Rank hold TPTX as of Q3 2022.

Carson Wealth (CWM LLC) reported no remaining Turning Point Therapeutics, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
Carson Wealth (CWM LLC) sold 4 Turning Point Therapeutics, Inc. Common Stock shares in Q3 2022.
Carson Wealth (CWM LLC) first reported a position in Turning Point Therapeutics, Inc. Common Stock in Q2 2019 and held it in 12 quarters.
Carson Wealth (CWM LLC)'s Turning Point Therapeutics, Inc. Common Stock position peaked at $1K in Q4 2021.
0 funds tracked by Wall St. Rank held Turning Point Therapeutics, Inc. Common Stock as of Q3 2022.

Based on Carson Wealth (CWM LLC)'s 13F filing for Q3 2022, filed 27 Oct 2022.